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The development of tissue engineering in the field of orthopedic surgery is booming. Two fields of research in
particular have emerged: approaches for tailoring the surface properties of implantable materials with
osteoinductive factors as well as evaluation of the response of osteogenic cells to these fabricated implanted
materials (hybrid material). In the present study, we chemically grafted insulin onto the surface of hydroxyapatite
nanorods (nHA). The insulin-grafted nHAs (nHA-I) were dispersed into poly(lactide-co-glycolide) (PLGA) polymer
solution, which was electrospun to prepare PLGA/nHA-I composite nanofiber scaffolds. The morphology of the
electrospun nanofiber scaffolds was assessed by field emission scanning electron microscopy (FESEM). After extensive
characterization of the PLGA/nHA-I and PLGA/nHA composite nanofiber scaffolds by Fourier transform infrared
spectroscopy (FTIR), X-ray diffraction spectroscopy (XRD), X-ray photoelectron spectroscopy (XPS), energy-dispersive
X-ray spectrometry (EDS), and transmission electron microscopy (TEM), the PLGA/nHA-I and PLGA/nHA (used as control)
composite nanofiber scaffolds were subjected to cell studies. The results obtained from cell adhesion, alizarin red
staining, and Von Kossa assay suggested that the PLGA/nHA-I composite nanofiber scaffold has enhanced osteoblastic
cell growth, as more cells were proliferated and differentiated. The fact that insulin enhanced osteoblastic cell
proliferation will open new possibilities for the development of artificial scaffolds for bone tissue regeneration.
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Polymeric fibers have been fabricated using various tech-
niques such as self-assembly, phase separation, melt spin-
ning, and electrospinning. Among these, electrospinning
is a unique, simple, cost-effective, versatile, and scalable
technique used for the fabrication of nanofibers from a
wide range of natural and synthetic polymers [1-4]. Elec-
trospinning is used frequently in the engineering, envi-
ronmental, and biomedical fields [5,6]. Fibrous scaffolds
prepared via electrospinning exhibit unique properties
such as a high surface area-to-volume ratio, ultrafine uni-
form fibers, having high porosity and variable pore size
distribution within the intra-fibrous structure [4]. These
properties serve to enhance the biocompatibility and* Correspondence: ikkang@knu.ac.kr
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in any medium, provided the original work is pbiological responses of the scaffold. The electrospinning
process is quite flexible; therefore, it provides more
efficient control over the nanofiber scaffold by altering
several governing experimental parameters, including po-
lymer concentration, voltage, and needle to collector
distance [7]. Until now, a variety of synthetic as well as
natural biopolymers have been used to date for the pre-
paration of fibrous scaffolds by electrospinning [8,9].
Among synthetic polymers, poly(lactide-co-glycolide)
(PLGA), a biodegradable polyester, has been studied ex-
tensively in the preparation of electrospun scaffolds. Apart
from biocompatibility, PLGA exhibits excellent biodegra-
dability over time and its degradation rate can be altered
by adjusting the monomer ratio [10,11]. A series of ex-
periments have concluded favorable cellular responses
to these nanofibrous scaffolds; Kim et al. demonstrated
enhanced osteoblast adhesion and proliferation onto elec-
trospun nanofiber scaffolds [1].n Open Access article distributed under the terms of the Creative Commons
g/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction
roperly credited.
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tals, nanorods, nanospheres, nanoparticles, and nanofibers
have unique properties, which cannot be achieved by
using pristine polymers. During the electrospinning
process, several inorganic fillers, including β-tricalcium
phosphate (β-TCP), hydroxyapatite nanorods (nHA), mul-
tiwall carbon nanotubes (MWCNT), and calcium car-
bonate (n-CaCO3) are successfully incorporated into the
polymer solution to fabricate biocomposite electrospun
scaffolds for tissue engineering [1]. HA is among one of
the widely used bioceramic material having similar com-
position and morphology to the inorganic component of
natural bone [12]. In addition, it can provide a favorable
environment for cell adhesion, osteoconduction, and
osteoinduction.
Controlling the surface energies enables us to precisely
control the surface and interfacial properties of nanoma-
terials ranging from wetting to adhesion, thus providing
an active site for chemical reactions and/or interactions
with foreign bodies. This can be achieved by tailoring the
surface of nanomaterials [2,13]. Recently, several reports
have described strategies for surface modification, inclu-
ding the chemical attachment of long or short-chain mol-
ecules to a wide range of surfaces or substrates [14,15].
Succinic acid is used as a surface modifier and carrier for
targeted drug delivery systems (DDS) on nanomaterial
surfaces due to its non-immunogenic, non-toxic, and
non-antigenic properties [16]. Succinic acid can alter the
physical and chemical properties of the substrates [17],
where the substrate surfaces modified by succinic acid are
more prone to chemical reactions with suitable functional
groups such as the primary amine group (NH2). The func-
tional groups provide active sites for the covalent conjuga-
tion of the protein with other macro- and micromolecules
and hence improve the biocompatibility and dispersion
properties of the substrate. The incorporation of bioactive
agents by mixing, encapsulation, or covalent bonding to
electrospun fibers could lead to advanced biofunctional
tissue engineering (TE) scaffolds [18]. The biofunctionali-
zation of electrospun fibers is, however, the most pro-
minent method used and determines the efficiency of
these fibers to regenerate biofunctional tissues. Insulin is a
peptide protein capable of regulating carbohydrate and fat
metabolism in the body [19]. It is highly effective in con-
trolling diabetes mellitus and is used in the treatment of
diabetes [20]. In addition, insulin is a well-known cell
growth factor capable of enhancing cell proliferation, in-
cluding activation of muscle stem cells [20-22]. Therefore,
several insulin-like growth factors were used previously in
the field of bone regeneration, which showed high bio-
compatibility and enhanced cell growth [23].
The aim of the present study was to enhance the cell
affinity, osteoconduction, and osteoinduction by grafting
insulin onto the surface of nHA by chemical reaction,which was used to fabricate three-dimensional electro-
spun PLGA/nHA-I composite nanofiber scaffolds. The
adhesion, proliferation, and differentiation of MC3T3
cells were investigated to evaluate the potential of the
PLGA/insulin-grafted nHAs (nHA-I) nanofiber compo-
site as a bone TE scaffold.
Methods
PLGA (lactide/glycolide 85:15), with molecular weight of
240,000, insulin from the human pancreas, and succinic
acid were purchased from Sigma-Aldrich (St. Louis, MO,
USA). nHA was synthesized in the laboratory. Minimal es-
sential medium (MEM)-alpha and the osteoblast MC3T3-
E1 cell line were purchased from the Korea cell bank
(Seoul, South Korea). 5-Bromo-2-deoxyuridine (Brdu)
and alizarin red staining kits were purchased from Roche
Molecular Biochemicals (Indianapolis, IN, USA) and
Millipore (Billerica, MA, USA), respectively. Fetal bovine
serum (FBS) and penicillin G-streptomycin were purchased
from Gibco, Tokyo, Japan. All reagents and chemicals in
this study were used without any further purification.
Synthesis of nHA
nHA was synthesized via chemical precipitation, as previ-
ously described [24]. Briefly, 400 ml (NH4)2PO3 and 300 ml
CaNO3 · 4H2O solutions were prepared separately by dis-
solving 19.75 g (NH4)2PO3 and 57.5 g (CaNO3) · 4H2O in
distilled water. The pH of (CaNO3) · 4H2O solution was
adjusted to 10.4 with NH4OH, after which the two solu-
tions were mixed dropwise with vigorous stirring. During
mixing, a white precipitate was formed, which was aged
for 4 days to form nHA. The synthesized nHA was
washed with distilled water until the pH reached 7. The
nHA was resuspended in 1-butanol to prevent nHA from
aggregation during the drying process. Finally, the preci-
pitate was dried at 80°C and calcined at 500°C for 4 h to
remove rudimental organic compounds.
Surface grafting of nHA via insulin
The grafting of insulin on the surface of nHA was carried
out in two steps. First, the carboxyl group (-COOH) was
introduced onto the nHA surface via a reaction between
succinic acid and surface hydroxyl groups of nHA. Subse-
quently, in the second step, insulin was grafted onto the
surface of succinic acid-modified nHA via chemical reac-
tion, between the amine group (NH2) of insulin and the
free terminal carboxylic group (COOH) of succinic acid
using water-soluble carbodimide (WSC). Briefly, an excess
amount of succinic acid was dissolved in distilled water
(DI). Then, the free carboxylic acid groups of succinic acid
were activated using WSC and kept for 6 h at room
temperature with gentle stirring to activate the terminal
carboxylic groups. After this activation step, nHA was
added to the aqueous solution of succinic acid and
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chloride (EDC, 0.5 g; 0.25 wt.%) and N-hydroxysuc-
cinimide (NHS, 0.05 g, 0.25 wt.% ) and kept for 6 h with
constant, gentle stirring. The succinic acid-grafted nHA
(nHA-s) were washed twice with double distilled water,
centrifuged at 13,000 rpm, and freeze-dried. In the second
step, the nHA-s were resuspended in an aqueous solution
containing WSC solution and stirred gently for 6 h at
room temperature in order to activate the free terminal
(COOH) group. This was followed by addition of an equal
amount of insulin corresponding to the amount of nHA-s.
The solution was stirred gently for 12 h at room tem-
perature to obtain nHA-I (Figure 1). The nHA-I was then
washed with distilled water to remove impurities and
freeze-dried.
Solution preparation and electrospinning
PLGA polymer solution in the concentration range of 5 to
20 wt.%, was prepared by dissolving in a binary solvent
(THF and DMF in a 3:1 ratio). The solution was stirred
overnight at room temperature until complete dissolution.
The solution was then subjected to electrospinning. For
this, the PLGA solution was placed into a 10-mL glass
syringe fitted with a needle of 0.9 mm (20 G) inner dia-
meter. A typical electrospinning setup consists of four
main components: (i) a pump, to hold and pump the
hypodermic syringe containing polymer solution, which
allowed controlled outflow of the polymer solution; (ii) a
high voltage supply of 1 to 50 kV; (iii) a metallic capillary
(needle) connecting the syringe to the positive voltage;
and (iv) a metallic collector (flat or rotating drum), whichFigure 1 Schematic diagram depicting grafting of insulin on the surfacan either be stationary or rotating) connected to negative
voltage. The electrospinning process began when a high
electric current was generated from the power supply.
The solution moved to the tip of the needle, and the hemi-
spherical shape of the droplet was destabilized by charges
that accumulated on its surface. As the charges balanced
the fluid surface tension of the polymer solution, the drop-
let was converted to a Taylor's cone with a semivertical
angle of approximately 30° [25]. At a critical electrical
voltage, the electric forces surpassed the surface tension of
the droplet and a jet of ultrafine fibers emanated from the
tip of the Taylor's cone and was collected onto the col-
lector kept at fixed distance [26]. Due to the high electric
voltage used in the process, the fluid jet usually remains
stable for a small distance (2 to 4 cm) before scattering.
The optimized electrospinning conditions used in the
present study were tip-to-collector distance 20 cm, applied
voltage 20 kV, needle diameter 20 G (0.9 mm), and flow
rate 1 mL/h. The electrospun nanofibers collected were
removed from the collector and dried overnight at 40°C to
remove the remaining solvent. After drying, the sample
was sputter-coated with gold and its morphology was ob-
served by field emission scanning electron microscopy
(FESEM; 400 Hitachi, Tokyo, Japan). The same procedure
was adapted for the preparation of the electrospun PLGA/
nHA-I and PLGA/nHA composite nanofiber scaffolds.
Briefly, both pristine nHA and insulin-grafted nHA-I were
added into the PLGA polymer solution and were mecha-
nically dispersed via alternate stirring and sonication.
After dispersion, the samples were subjected to electro-
spinning process.ce of nHA.
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To examine the interaction of the PLGA/nHA-I and
PLGA/nHA composite nanofiber scaffolds with osteoblastic
cells (MC3T3-E1), the composite nanofiber scaffolds were
cut into small circular discs, fitted inside a 4-well culture
dish, and immersed in MEM medium containing 10% FBS
(Gibco; Invitrogen, Carlsbad, CA, USA). Subsequently,
1 mL of the MC3T3-E1 cell solution (3 × 104 cells/mL)
was added to the surface of the composite nanofiber scaf-
folds and incubated in a humidified atmosphere con-
taining 5% CO2 at 37°C for 1 and 3 days. After incubation,
the supernatant was removed and the composite nano-
fiber scaffolds were washed twice with phosphate-buffered
saline (PBS; Gibco, Langley, OK, USA) and fixed in a 2.5%
glutaraldehyde solution for 15 min. The samples were
then dehydrated, dried in a critical point drier, and
sputter-coated with gold. The surface morphology of the
composite nanofiber scaffolds was observed by FESEM
(400 Hitachi; Tokyo, Japan).
Cytoskeletal organization
To evaluate the cytoskeletal organization of cells onto the
PLGA/nHA-I and PLGA/nHA composite as well as pris-
tine PLGA nanofiber scaffolds, double staining was per-
formed according to the manufacturer's protocol. Briefly,
osteoblast cells were seeded onto the scaffolds (2 × 104
cells/mL) and were cultured for 3 days. The cells were
fixed with 4% paraformaldehyde in PBS. After fixation, the
samples were washed using PBS buffer solution containing
(0.05% Tween-20). The samples were permeabilized with
0.1% Triton X-100 in PBS for 15 min at 25°C and then
incubated for 30 min in PBS containing 1% bovine serum
albumin (BSA). This was followed by the addition of
5(6)-tetramethyl-rhodamine isothiocyanate-conjugated
phalloidin (Millipore) (TRITC) for approximately 1 h. The
samples were washed three times (10 min each) using the
buffer solution and incubated with 4′,6-diamidino-2-
phenylindole (DAPI) (Millipore) for 5 min. Fluorescence
images were visualized using a confocal laser scanning
microscope (model 700; Carl Zeiss, Oberkochen, Germany)
after washing the scaffolds three times (10 min each) with
the buffer solution.
Cell proliferation
Proliferation of MC3T3 osteoblastic cells seeded on the
PLGA/nHA-I, PLGA/nHA composite, and pristine PLGA
nanofiber scaffolds was determined using a colorimetric
immune assay, based on the measurement of BrdU, which
was incorporated during DNA synthesis. BrdU enzyme-
linked immunosorbent assay (ELISA; Roche Molecular
Biochemicals) was performed according to the manufac-
turer's instructions. Briefly, after cell culture for 48 h,
BrdU-labeling solution was added to each well. The solu-
tion was allowed to incorporate into the cells in a CO2incubator at 37°C for 20 h. Subsequently, the supernatant
in each well was removed by pipetting and washed twice
with PBS. The cells were treated with 0.25% trypsin-
ethylenediaminetetraacetic acid (EDTA) (Gibco, Tokyo,
Japan) and harvested by centrifugation of the cell solution
at 1,000 rpm for 15 min. The harvested cells were mixed
with FixDenat solution to fix the cells and denature the
DNA and then incubated for 30 min. Subsequently, di-
luted anti-BrdU peroxidase (dilution ratio of 1:100) was
added to the cells and incubated at 20°C for 120 min.
After removing the unbound antibody conjugate, 100 μL
substrate was added and allowed to stand for 20 min. The
reaction was completed by adding 25 μL H2SO4 solution
(1 M). The solution was then transferred to a 96-well plate
and measured within 5 min at 450 nm with a reference
wavelength of 690 nm, using an ELISA plate reader
(EL 9800). The blank reading corresponded to 100 μL of
culture medium with or without BrdU.
Alizarin red staining
Alizarin red staining of the MC3T3 osteoblastic cells
cultured on the electrospun PLGA/nHA-I, PLGA/nHA,
and pristine PLGA nanofiber scaffolds was performed to
examine mineralization and differentiation. Briefly, after
culturing the MC3T3 osteoblasts, the medium was aspi-
rated without disturbing the cells. The culture dish with
the osteoblastic cells was washed twice with PBS. The
cells were then fixed with 10% formaldehyde and incu-
bated for 15 min at room temperature. The fixative re-
agent was removed carefully, and the cells were rinsed
three times (10 min each) with distilled water to avoid
disturbing the monolayer. After washing, the excess
water was removed and alizarin red staining solution
(1 mL/well) was added to the cells and the samples were
incubated for 30 min. Subsequently, the excess amount
of dye was removed from the stained cells by washing
the samples four times with distilled water (5 min each)
with gentle rocking. Digital images of the stained cells
were obtained with a camera (Nikon E 4500, Tokyo,
Japan).
Von Kossa assay
Calcium deposition of MC3T3-E1 cells was examined by
Von Kossa staining. The cells were cultured for 15 days
on PLGA/nHA-I, PLGA/nHA, and pristine nanofiber
scaffolds under the same conditions as those described in
the alizarin red staining experiment. After incubation, the
cells were washed three times with PBS for 5 min, fixed
with 10% formaldehyde for 30 min, and washed three
times with distilled water for 10 min. The fixed samples
were treated with 5% AgNO3 solution for 5 min under
ultraviolet radiation. After removing the AgNO3 solution,
the samples were washed with PBS twice followed by the
addition of 5% Na2S2O3 solution to the plate and allowing
(a) (b) (c)
100μm 100μm100μm
Figure 2 FESEM images of (a) pristine PLGA, (b) PLGA/nHA, and (c) PLGA/nHA-I nanofiber scaffolds.
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washed twice with distilled water and digital images of the
stained cells were obtained.
Statistical analysis
The results are displayed as the mean ± standard devia-
tion. The statistical differences were determined using a
student's two-tailed test. Scheffe's method was used for
the multiple comparison tests at a level of 95%.
Results and discussion
Preparation of nanofiber scaffolds
Figure 2 illustrates the FESEM images of the electrospun
PLGA/nHA-I, PLGA/nHA, and pristine PLGA nanofibers
scaffolds. With optimized electrospinning parameters, no
remarkable change was observed in the morphology of
pristine PLGA, PLGA/nHA, or PLGA/nHA-I composite
nanofiber scaffolds. The nanofibers were smooth and
beadless in all the samples. However, the average diame-
ters of PLGA/nHA (mean average diameter 500 nm) and












Figure 3 FTIR spectra of (a) pristine nHA, (b) nHA-I, (c) pristine PLGA,nanofibers increased slightly as compared to pristine
PLGA nanofiber having (mean average diameter 450 nm).
This increase in the average diameter might be due to the
incorporation of pristine nHA and nHA-I in the PLGA
polymer matrix. A similar increase in the average diameter
of the modified nanofibers has been also reported else-
where [27].
Fourier transform infrared spectroscopy study
Figure 3 illustrates the Fourier transform infrared
(FTIR) spectra of the pristine nHA, nHA-I, pristine
PLGA, and PLGA/nHA-I composite nanofiber scaffolds.
The sharp band, which appeared in the regions of 1,000
to 1,100 cm−1 in the pristine nHA spectrum is characteris-
tic of a regular tetrahedral (PO4
−3) of nHA (Figure 3(a))
[28,29]. The appearance of weak doublet bands in the
region of 2,800 cm−1 to 3,200 cm−1 in nHA-I spectrum
(Figure 3(b)) was attributed to hydrocarbons (CH, CH2) of
succinic acid [30]. The two sharp bands at 1,648 and
1,540 cm−1 were attributed to the stretching vibration of






















































Figure 4 XPS graph of (a) pristine nHA, (b) nHA-I, (c) pristine PLGA nanofiber scaffold, and (d) PLGA/nHA-I nanofiber composite
scaffolds.
Table 1 Chemical composition of nanofiber scaffolds
calculated from ESCA (XPS) survey scan spectra
Substances Atomic weight (%)
C 0 Ca N P S
nHA 7.7 66.6 17.8 12.6
PLGA 64.61 35.39
nHA-I 47.77 30.90 11.51 6.75 5.2 0.76
PLGA/nHA-I 63.38 27.40 4.12 3.10 2.75 0.25
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II (-CO-NH) [31]. The appearance of these bands at their
characteristic positions confirmed the grafting insulin on
the surface of succinic acid-modified nHA-s. The band at
3,500 cm−1 was attributed to the free carboxylic acid
(COOH) moiety present in insulin [28]. A sharp peak
at 1,742 cm−1 appeared in the PLGA polymer spectrum
(Figure 3(c)), which was assigned to the C =O stretching
of PLGA polymers. Similarly, the bands at 2,800 to
3,200 cm−1 were assigned to hydrocarbons (CH, CH2)
[30]. In the spectrum of the PLGA/nHA-I (Figure 3(d)),
all the abovementioned bands were present at their cha-
racteristic positions. However, the reduced intensities of
the bands for amide and carboxylic functionalities might
be attributed to the influence of the excess amount of
PLGA used.
X-ray photoelectron spectroscopy analysis
The successful grafting of insulin on nHA using succinic
acid as a spacer was confirmed by X-ray spectroscopy
(XPS) (ESCA). Figure 4 shows the data obtained from the
qualitative analysis of pristine nHA, nHA-I, PLGA, and
PLGA/nHA-I. The N1s and S2p photoelectron signals were
the markers of choice for confirmation of insulin grafting
on the surface of succinic acid-modified nHA-s and the
presence of insulin-grafted nHA-I in the PLGA nanofibers.
nHA showed three photoelectron signals (Figure 4(a)), cor-
responding to Ca2p (347.9 eV) and O1s (binding energy
536.1 eV) along with P2p (binding energy, 133.2 eV).
Whereas PLGA (Figure 4(c)) showed two photoelectronsignals, representing C1s (binding energy, 284.6 eV) and
O1s (binding energy, 536.1 eV). On the other hand, two
new photoelectron signals were observed for the PLGA/
nHA-I composite (Figure 4(d)) and nHA-I (Figure 4(b)),
namely, representing nitrogen (N1s, at binding energy
397.9 eV) and sulfur (S2p, binding energy 164.05 eV), re-
spectively. This confirmed successful grafting of insulin on
the surface of pristine nHA Figure 4(b), and the presence of
insulin-grafted nHA-I in the PLGA composite nanofiber
scaffold PLGA polymer (Figure 4(d)).
Table 1 shows that the atomic wt.% of nitrogen (N)
and sulfur (S) was zero in pristine nHA and PLGA.
However, when the surface of nHA was modified with
succinic acid and subsequently on grafting with insulin,
the atomic wt.% of calcium (Ca) and phosphorous (P)
decreased, whereas those of carbon (C), nitrogen (N),
and sulfur (S) increased due to succinic acid and further
grafting of insulin on the surface of nHA. This increase
in atomic wt.% clearly indicated that succinic acid and
insulin had been successfully grafted onto pristine nHA.
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Figure 6 TEM images of (a) pristine nHA, (b) nHA-I, (c) PLGA/nHA, and (d) PLGA/nHA-I with their respective EDX graphs. Depicting their
characteristics peaks and chemical compositions.
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% of calcium (Ca), phosphorous (P), nirtogen (N), and
sulfur (S) decreased whereas the atomic wt.% of carbon
(C) increased, confirming the presence of nHA-I in the
PLGA nanofiber matrix.
X-ray diffraction spectroscopy study
Figure 5 depicts the X-ray diffraction spectroscopy
(XRD) profile of pristine nHA and nHA-I. From the
XRD profile, it is evident that grafting of insulin had no
adverse effect on the crystallinity of nHA. The charac-
teristic diffraction peaks of nHA before and after graft-
ing of insulin appeared at 26.1°, 28.45°, 30.1°, 32.90°,
35.97°, 40.19°, 41.82°, 53.56°, 55.75°, 57.40°, 69.12°,
74.45°, and 77.56°, corresponding to the 002, 102, 210,
112, 300, 212, 130, 213, 321, 004, and 104 planes, re-
spectively, of the nHA unit cell with hexagonal sym-
metry. The peaks were at the same positions in both
pristine nHA and nHA-I [28]. From the XRD profile of
pristine nHA and nHA-I, it was found that the crystal-
linity of the nHA was intact even after grafting with
insulin.
Transmission electron microscopy (TEM) morphology
study
The morphology of pristine nHA and nHA-I embedded
in the PLGA matrix was observed under TEM. Figure 6a,
b illustrates the TEM images of pristine nHA and nHA-I.
From the TEM images, it is obvious that nHA-I (Figure 6b)
was well dispersed as compared to pristine nHA (Figure 6a),






Figure 7 SEM images of the osteoblast adhesion on (a, d) pristine PLG
3 days (d, e, f) of incubation.carbon grid. Dispersion of nHA in the PLGA nanofiber
scaffold was improved by the incorporation of insulin to
the nHA (nHA-I) as compared to the pristine and grafted
nHA. Energy-dispersive X-ray spectroscopy (EDX) data in
the downset of Figure 6a,b show the characteristic peaks
of calcium (Ca), phosphorus (P), and oxygen (O) for pris-
tine nHA (Figure 6a) and calcium (Ca), phosphorus (P),
nitrogen (N), and sulfur (S) for nHA-I (Figure 6b). The
presence of these peaks endorsed that the dispersed mate-
rials were pristine nHA and nHA-I. Furthermore, charac-
teristic EDX peaks of pristine nHA and nHA-I were also
observed for PLGA/nHA (Figure 6c) and PLGA/nHA-I
composite nanofiber scaffolds (Figure 6d). This confirms
the presence of nHA and nHA-I in PLGA/nHA (Figure 6c)
and PLGA/nHA-I composite nanofiber scaffolds (Figure 6d).
Figure 6c,d depicts the morphology of the composite
nanofibers. The composite nanofibers were uniform, with
pristine nHA and nHA-I embedded in the PLGA electro-
spun nanofibers. Because of its hydrophilic nature, pristine
nHA showed restricted dispersion in the hydrophobic
PLGA polymer (Figure 6c) [32]. However, on the other
hand, grafting of insulin on the surface of pristine nHA
enhanced the dispersion of nHA in the PLGA polymer
matrix (Figure 6d) [33]. The relatively uniform dispersion
of nHA-I in the PLGA polymer matrix was beneficial for
the osteoblastic cell adhesion analysis because one portion
of the nHA-I was embedded while the rest protruded
from the electrospun PLGA/nHA-I composite nanofibers
surface. The protrusion of nHA-I made the surface of the
PLGA/nHA-I rough. Thus, more cells were able to adhere



































Figure 8 Proliferation of osteoblast cells cultured on the pristine PLGA, PLGA/nHA, and PLGA/nHA-I nanofiber scaffolds. For 2 days as
determined by a Brdu assay.
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nanofibers (Figure 7) [34]. The protrusion of nHA-I origi-
nated due to the phase separation between the hydrophilic
nHA-I and the hydrophobic PLGA polymer matrix [35].
Bioactivity and cellular response
The adhesion behavior of the osteoblastic cells to implant-
able materials is determined mostly by their surface chem-
istry and topography [36]. To elucidate the in vitro
osteoblastic cell behavior and assess the effectiveness of in-
sulin grafting onto the surface of nHA, osteoblastic cells
were cultured on pristine PLGA nanofiber scaffolds as well
as PLGA/nHA and PLGA/nHA-I composite nanofiber
scaffolds. As depicted in Figure 7, more cells adhered to the
PLGA/nHA-I composite nanofiber scaffolds (Figure 7c,f)
contrary to the PLGA/nHA composite (Figure 7b,e) and
pristine PLGA nanofiber scaffolds (Figure 7a,d). The in-
creased adhesion of osteoblastic cells to PLGA/nHA-I com-




Figure 9 Confocal laser scanning micrograph of osteoblasts. Actin (re
after 3 days of incubation.nHA-I in the PLGA nanofiber scaffold (PLGA/nHA-I) and
to the rough morphology of the PLGA/nHA-I composite
nanofiber scaffolds due to the protrusion of the nHA-I
from the PLGA nanofiber scaffolds (Figure 6d). Insulin has
the capability of enhancing cell growth [20,22], whereas
protrusion makes the surface of the scaffold rough. Osteo-
blastic cells adhesion was enhanced in both cases
[20,22,34,36]. The order of increase in cell adhesion and
spreading of osteoblastic cells was PLGA/nHA-I > PLGA/
nHA > PLGA. Besides the type of scaffolds, adhesion of the
osteoblastic cells was also increased with an increase in in-
cubation time from 1 to 3 days. In addition to better adhe-
sion, more spreading of osteoblastic cells was observed on
the PLGA/nHA-I composite nanofiber scaffold as com-
pared to the PLGA/nHA composite and pristine PLGA
nanofiber scaffolds.
Figure 8 represents the results obtained from the Brdu
assay after culturing osteoblastic cells on pristine PLGA,
PLGA/nHA, and PLGA/nHA-I composite nanofiber(c)
50µm
d). Nucleus (blue). (a) Pristine PLGA, (b) PLGA/nHA, and (c) PLGA/nHA-I
(a) (b) (c)
Figure 10 Alizarin red staining of osteoblast cells cultured for 15 days. On (a) PLGA, (b) PLGA/nHA, and (c) PLGA/nHA-I nanofiber scaffolds.
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http://www.nanoscalereslett.com/content/9/1/314scaffolds. The proliferation of the osteoblastic cells on
the PLGA/nHA-I composite nanofiber scaffold was bet-
ter as compared to the PLGA/nHA composite and pris-
tine PLGA nanofiber scaffolds. This was attributed to
the widely accepted role of insulin as a cell growth factor
[21]. These results indicated that insulin played a vital
role in stimulating growth and proliferation of mature
osteoblastic cells by enhancing the biocompatibility of
the PLGA/nHA-I composite nanofiber scaffold. Thus,
more osteoblastic cells proliferated on the PLGA/nHA-I
composite nanofiber scaffold as compared to the PLGA/
nHA composite and pristine PLGA nanofiber scaffolds.
Figure 9 represents confocal laser microscope images of
the nucleus and actin cytoskeleton staining of the osteo-
blastic cells cultured on pristine PLGA, PLGA/nHA, and
PLGA/nHA-I composite nanofiber scaffolds for 3 days.
The actin microfilament cytoskeleton is involved in cellu-
lar processes, determining cell shape, and cell attachment.
As the cell adheres to a substrate material, filopodia are
formed. They are moved into place by actin acting upon
the plasma membrane. Our results showed that the degree
of cytoskeletal organization strongly increased on PLGA/
nHA-I nanofiber scaffolds (Figure 9c) contrary to the
PLGA/nHA composite (Figure 9b) and pristine PLGA
nanofiber scaffolds (Figure 9a). The organized cytoskel-
eton can exert forces onto the substratum, thus orientat-
ing the matrix. This ordered extracellular matrix can in
turn orientate with the cytoskeleton of other cells that
come into contact with it, ultimately creating a large-scale
organization.(a) (b)
Figure 11 Von Kossa assay of the osteoblast cells. On the (a) PLGA, (bAlizarin red staining
Differentiation of osteoblastic cells is one of the most
important parameters for confirming osteogenesis of
osteoblastic cells cultured on the scaffolds [37]. To con-
firm osteogenesis, alizarin red staining is considered as
one of the marker specific for differentiation of osteo-
blastic cells [38]. Figure 10a,b,c shows that osteoblastic
cells underwent osteogenesis process on all of the scaf-
folds. The osteogenesis process was determined from
the appearance of the red color, which is an indicator of
calcium production by osteoblastic cells. More cells were
differentiated on the PLGA/nHA-I composite nanofiber
scaffold (Figure 10c, dark red color) compared to the
PLGA/nHA composite (Figure 10b, light red color) and
pristine PLGA (Figure 10a, grayish color) nanofiber scaf-
folds. These results suggest that grafting of insulin on
the nHA surface accelerated the differentiation of osteo-
blastic cells [38].
Von Kossa assay
Figure 11 illustrates the results of the Von Kossa assay
performed on the PLGA/nHA-I, PLGA/nHA composite,
and pristine PLGA nanofiber scaffolds. Bone nodules are
considered to be one of the markers specific to osteo-
blastic cell differentiation. In the Von Kossa assay, the
calcified area is stained as black spot. The results ob-
tained from the Von Kossa assay suggest that more bone
nodules were formed on the PLGA/nHA-I (Figure 11c)
contrary to the PLGA/nHA (Figure 11b) composite and
pristine PLGA (Figure 11a) nanofiber scaffolds [1]. The(c)
) PLGA/nHA, and (c) PLGA/nHA-I scaffolds after 15 days of incubation.
Haider et al. Nanoscale Research Letters 2014, 9:314 Page 11 of 12
http://www.nanoscalereslett.com/content/9/1/314Von Kossa assay results clearly suggested that insulin
triggered and accelerated osteoblastic cell differentiation
(Figure 11c) [20]. The high calcification area obtained
from PLGA/nHA-I by the assessment of the scaffolds
using Von Kossa assay was well matched with the dark
red color obtained from PLGA/nHA-I using alizarin red
staining as depicted in Figure 10c. Furthermore, PLGA/
nHA composite nanofiber scaffolds showed enhanced
cell differentiation (Figure 10b and 11b) due to the nHA
effect as compared to the pristine PLGA nanofiber scaf-
folds (Figure 10a and 11a). The order of osteoblastic cell
differentiation of the scaffolds was pristine PLGA <
PLGA/nHA < PLGA/nHA-I [24].
Conclusions
Insulin was grafted on the surface of hydroxyapatite
nanorods to produce surface-modified (nHA-I) compo-
site nanofiber scaffolds, composed of PLGA and nHA-I
obtained by blending of nHA-I with PLGA and subse-
quent electrospinning. After confirming the presence of
nHA-I in the PLGA matrix, the scaffolds were subjected
to the cell culture studies for assessing their biocom-
patibility and bioactivity. The results obtained from the
in vitro studies indicate that the cell adhesion, proli-
feration, and differentiation of the osteoblastic cells were
accelerated on PLGA/nHA-I composite nanofiber scaf-
fold as compared to PLGA/nHA composite and pristine
PLGA nanofiber scaffolds. This study will prove a poten-
tial step forward in triggering research on bone tissue
engineering, bone remodeling, artificial bone implan-
tation, and site-specific drug delivery for various bone
diseases.
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